Effects of Weight Loss Intervention on Biomarkers of Nonalcoholic Fatty Liver Disease
Evidence supports changing clinical practice guidelines to recommend formal weight loss programs for people with NAFLD.
Obesity
Regional Fat With Normal BMI Affects CVD Risk After Menopause
Higher percent trunk fat and lower percent leg fat linked to increased risk of cardiovascular disease
Estradiol May Protect Against Cognitive Impairment Mediated by Visceral Adiposity
Estradiol has anti-inflammatory properties and can strengthen the hypothalamic-pituitary-adrenal axis, which may oppose the effects of visceral adiposity.
Artificial Light Exposure While Sleeping Linked to Weight Gain, Obesity in Women
Artificial light exposure at night should be addressed in obesity prevention discussions.
Higher Risk for T2D in Offspring of Women With Maternal Overweight, Obesity
Maternal obesity and overweight are associated with an increased risk for type 2 diabetes in offspring.
Avexitide Granted Breakthrough Therapy Designation for Post-Bariatric Hypoglycemia
FDA has granted Breakthrough Therapy designation to avexitide (Eiger Biopharmaceuticals) for the treatment of post-bariatric hypoglycemia (PBH).
The Impact of Preconception Maternal BMI on Child Obesity
Results from a systematic review and meta-analysis found that prepregnancy maternal obesity is associated with a significantly increased risk for child obesity.
Obesity During Adolescence Linked to Stiffening of Arteries
This adverse effect is further aggravated by an unfavorable metabolic profile
Labeling Updated for Orbera Intragastric Balloon System to Include New Safety Data
The Food and Drug Administration (FDA) has approved updates to the Orbera Intragastric Balloon System (Apollo Endosurgery, Inc.) labeling to improve patient safety.
The Case for Weight-Neutral Diabetes Care: Part 1
To learn more about weight-neutral diabetes care, Endocrinology Advisor checked in with experts in the field to discuss existing research and takeaways for clinicians.
Next post in Diabetes
